Tag: U.S. Government Accountability Office


What I told Congress about Patient Access to Experimental Medicines

October 17, 2017

Via: Forbes

Early this month, I went to Washington, D.C., to serve as a witness for a hearing on “Examining Patient Access to Investigational Drugs” held by the Subcommittee on Health of the House of Representatives’ Committee on Energy and Commerce. The […]